• Recognize the controversies of the gut microbiome, making fecal microbiota transplantation (FMT) the most effective microbial therapeutic to date
• Recognize primary and secondary dysbioses as potential candidates for FMT
• Define recipient, donor, preparation, placebo, and regulatory considerations for FMT and clinical trial design

• Define high risk pediatric patients undergoing GI procedures
• Discuss pre-operative preparation as a means to mitigate risk
• Identify practices which may increase safety during endoscopy in high risk patients

The evaluation and management for patients with very early onset inflammatory bowel disease
Judith Kelsen, MD, Children's Hospital of Philadelphia
Objectives:

• Understand the components of the initial evaluation of very young children who present with symptoms of IBD
• Recognize the signs and symptoms of the most common forms of monogenic VEO-IBD
• Understand the different genetic sequencing options and when these studies are appropriate to perform
• Understand the therapeutic approaches for specific monogenic defects in patients with VEO-IBD

• At the conclusion of this activity participants will be able to differentiate between the major hereditary polyposis syndromes relevant in the pediatric age group based on clinical, endoscopic-histologic and genetic testing findings
• Activity participants will be able to formulate an endoscopic-intestinal and extraintestinal screening and surveillance plan of care based on the specific polyposis subtype